Bio-Techne
Manufacturing · Minnesota, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
614 Mckinley Pl NE, Minneapolis, Minneso...Phone Number
(612) 379-2956Website
www.bio-techne.comRevenue
$1.2 BillionStock Symbol
TECHIndustry
About Bio-Techne
Bio-Techne Org Chart
Is Bio-Techne your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Bio-Techne recently announced quarterly report
Click to see if Bio-Techne had a recent Job posting/layoffs
Check out if Bio-Techne is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Bio-Techne
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Bio-Techne has new funding data
Check if Bio-Techne has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Bio-Techne, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Bio-Techne launches new products
Recommended Actions
Find VP level buyers at Bio-Techne
Find more new buyers
Company Profile Activity
Activity Insights
Bio-Techne is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Bio-Techne is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Bio-Techne.
Bio-Techne Tech Stack
A closer look at the technologies used by Bio-Techne
Most Recent Scoops
Bio-Techne News & Media
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fulcrum Therapeutics, Inc. (Nasdaq – FULC), Weave Communications, Inc. (NYSE – WEAV), Iridium Communications Inc. (Nasdaq – IRDM), Bio-Techne Corporation (Nasdaq – TECH)
BALA CYNWYD, Pa., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.Bio-Techne Corrects Dividend Announcement
MINNEAPOLIS, Aug. 13, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) is issuing a correction to its dividend announcement released yesterday. The initial version incorrectly stated the shareholder of record date as August 17, 2026. The correct shareholder of record date is...Bio-Techne Releases Fourth Quarter Fiscal 2026 Results
MINNEAPOLIS, Aug. 12, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ending June 30, 2026. Fourth Quarter FY2026 Highlights Fourth quarter organic revenue increased by 3% (1% reported) to $321.2 million. Full year...Bio-Techne Declares Dividend
MINNEAPOLIS, Aug. 12, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended June 30, 2026. The quarterly dividend will be payable August 28, 2026, to all common shareholders...
Top Manufacturing Companies
Frequently Asked Questions Regarding Bio-Techne
Founded in 1981, Bio-Techne Corporation is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and prov... Read More

